Spelling suggestions: "subject:"rats SHR"" "subject:"cats SHR""
1 |
Efeito da utilização de agentes hipouricemiantes sobre a pressão arterial de animais espontaneamente hipertensos / Uric acid lowering agents reduces blood pressure in spontaneous hypertensive ratsNicolielo, Renato Luiz Cursino, 1971- 14 August 2018 (has links)
Orientador: Marilda Mazzali / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas / Made available in DSpace on 2018-08-14T09:11:43Z (GMT). No. of bitstreams: 1
Nicolielo_RenatoLuizCursino_M.pdf: 2896438 bytes, checksum: 3df4ea3bde6ce115708b78e7b010be98 (MD5)
Previous issue date: 2009 / Resumo: Hiperuricemia é associada ao desenvolvimento de remodelamento vascular e hipertensão arterial em modelos experimentais. Por outro lado, o uso de agentes redutores dos níveis de ácido úrico (hipouricemiantes) proporciona a normalização pressórica e proteção contra o desenvolvimento de doença renal. Objetivo: Determinar o efeito de agentes hipouricemiantes sobre a pressão arterial de animais SHR. Métodos: ratos machos SHR e WKY, com 4 semanas de idade, acompanhados durante 9 semanas. Os animais SHR foram tratados com alopurinol (SHRALP) ou benzbromarona (SHRBENZ). Pressão arterial de cauda, função renal e histologia renal foram comparados aos animais SHR não tratados (SHRCT) e aos controles normotensos WKY (WKYCT). Pressão arterial de cauda foi medida no período inicial e semanalmente até o sacrifício. Resultados: Tratamento com agentes hipouricemiantes reduziu a PA em animais SHR, com melhor controle no grupo SHRALP (SHRCT 214±7,7; SHRALP 164±3,5; SHRBENZ 179±2,3 mmHg, p<0,05). O tratamento foi associado com redução significativa dos níveis de ácido úrico comparado aos controles SHR (SHRCT 1,6±0,6; SHRALP 0,9±0,2*; SHRBENZ 1,0±0,4* mg/dl, *p<0.05). A função renal permaneceu inalterada em todos os grupos durante o acompanhamento. Análise histológica dos fragmentos renais mostrou redução significativa do percentual de arteríolas pré-glomerulares remodeladas nos animais tratados, em comparação aos controles SHR (84,3±8,5%SHRCT; 66,4±20,1%SHRALP*; 71,6±15,3% SHRBENZ* p<0,05). Espessamento de arteríolas pré-glomerulares, quantificada por método de captura de imagem computadorizada mostrou redução significativa da área de parede arteriolar nos animais tratados em comparação aos SHR não tratados (SHRCT). A espessura arteriolar do grupo SHRALP foi compatível a dos animais controles WKY. Conclusão: O uso de agentes hipouricemiantes foi associado com redução de PA e de remodelamento vascular de arteríolas préglomerulares em animais SHR. Como esses animais já apresentam nível sérico de ácido úrico mais elevado que os WKY com 4 semanas de vida, apesar de níveis pressóricos normais, intervenção em idades mais precoces talvez possa prevenir o desenvolvimento de hipertensão arterial e remodelamento vascular nestes animais. / Abstract: Hyperuricemia is associated with vascular remodeling and hypertension in experimental models, and use of uric acid (UA) lowering agents is associated with BP normalization and protection of renal disease. Aim: To determine the effect of UA lowering agents on BP in SHR animals. Methods: Male SHR and WKY rats, 4 weeks old, were followed for 9 weeks. SHR animals received allopurinol (SHRALP) or benzbromarone (SHRBENZ) and BP, renal function, and renal histology were compared to untreated SHR (SHRCT) and WKY controls (WKYCT). Blood pressure was measured at baseline and every week until sacrifice. Results: Treatment with UA lowering agents reduced BP in SHR, with better control in SHRALP group (SHRCT 214±7.7, SHRALP 164±3.5, SHRBENZ 179±2.3 mmHg, p<0.05). Treatment was associated with a significant reduction in serum UA levels compared to SHRCT (SHRCT 1.6±0.6, SHRALP 0.9±0.2*, SHRBENZ 1.0±0.4* mg/dl, *p<0.05). Renal function remained unchanged in all groups. Histological analysis showed a significant reduction in vascular remodeling in SHR treated with UA-lowering agents compared to SHRCT (84.3±8.5%SHRCT, 66.4±20.1%SHRALP*, 71.6±15.3% SHRBENZ* p<0.05). Pre-glomerular arterial thickness, measured by computer assisted analysis, showed a reduction in arteriolar wall area in SHR treated compared to SHRCT. Arteriolar thickness in SHRALP group was comparable to WKYCT. Conclusion: The use of UA lowering agents was associated with a reduction in BP and pre glomerular arteriolopathy in SHR. As SHR rats already had higher UA than WKY controls at 4 weeks of life, despite normal BP, an earlier intervention might prevent the development of hypertension and vascular remodeling in these animals. / Mestrado / Ciencias Basicas / Mestre em Clinica Medica
|
2 |
Timing, reward processing and choice behavior in four strains of rats with different levels of impulsivity.Garcia Aguirre, Ana I. January 1900 (has links)
Master of Science / Department of Psychology / Kimberly Kirkpatrick / Several studies have examined timing and impulsive choice behavior in spontaneously hypertensive rats (SHR) as a possible pre-clinical model for Attention Deficit Hyperactivity Disorder (ADHD). However, the strain has not been specifically selected for the traits of ADHD and as a result their appropriateness as a model has been questioned. This study investigated whether SHR would exhibit timing deficits, poor reward processing and impulsive behavior in comparison to the Wistar Kyoto (WKY) control strain in a discrete-trial choice task. In addition, as a first approach to find another potential animal model of ADHD, we evaluated a strain that has shown high levels of impulsivity, the Lewis (LEW) rats and compared them with the Wistar (WIS) rats. In the first phase of the experiment, rats could chose a lever associated with a Smaller-sooner (SS) reward of 1 pellet delivered after 10 s and a Larger-later (LL) reward of 2 pellets delivered after 30 s. Subsequently, the rats were exposed to different phases, where the reward on the LL choice was increased to 3 and 4 pellets and where the delay to the SS choice was increased to 15 and 20 s. The SHR and WKY strains did not differ in their timing or choice behavior. In comparison to WIS, LEW showed timing deficits in both manipulations and deficits in choice behavior in the delay manipulation, indicating deficits in time processing. Individual differences among the rat within a strain accounted a significant proportion of the total variance and contributed more variance than the strain of the rat. These results indicate that the SHR and LEW strains are not sufficiently homogeneous with respect to impulsive choice behavior to be considered as viable models for impulse control disorders such as ADHD.
|
3 |
Etude préclinique par imagerie métabolique du TDAH : caractérisation des mécanismes physiopathologiques et des réponses aux traitements pharmacologiques / Preclinical metabolic imaging study of ADHD : characterization of pathophysiologic mechanism and response to pharmacologic treatmentsDesfosses, Emilie 08 July 2016 (has links)
Le trouble déficit de l’attention avec ou sans hyperactivité (TDAH) est une maladie neurodéveloppementale de l’enfant et de l’adulte caractérisée par un déficit attentionnel, une impulsivité et une hyperactivité. La physiopathologie de cette maladie demeure non élucidée, néanmoins des stratégies thérapeutiques médicamenteuses s’avèrent efficaces. En France, le médicament utilisé dans le traitement du TDAH est le méthylphénydate (MPH) qui est un psychostimulant, et deux autres molécules paraissent prometteuses : le dymésilate de lisdexamfétamine (LDX - psychostimulant) et la guanfacine (GFC - non psychostimulant). Les cibles moléculaires de ces médicaments sont bien connues mais l’impact de ces traitement en aigu et chronique sur le fonctionnement cérébral est pour l’instant peu documenté. L’objectif de cette thèse a été d’étudier (i) la physiopathologie du TDAH et (ii) les effets de ces traitements du TDAH en aigu et en chronique sur un versant préclinique et à l’aide de l’imagerie microTEP couplée au 2-deoxy-2-(18F)fluoro-d-glucose (18FDG). Dans la première étude, des modèles animaux du TDAH ont été utilisés : des rats SHR/NCrl présentanttroubles de l’attention, hyperactivité et impulsivité et des rats WKY/NCrl présentant uniquement des troubles de l’attention. Une imagerie microTEP au 18FDG sur animal éveillé a été réalisée sur ces animaux adultes afin d’obtenir leurs profils d’activité cérébrale. Notre hypothèse était que les rats SHR/NCrl et WKY/NCrl présenteraient des modifications de capture de 18FDG similaires qui seraient impliquées dans le trouble attentionnel commun aux deux souches, alors que les rats SHR/NCrl présenteraient aussi des modifications non retrouvés chez les WKY/NCrl qui joueraient un rôle dans la genèse de l’hyperactivité-impulsivité. Cettehypothèse a été confirmée par nos résultats montrant des dysfonctions fronto-striatales limbiques et du réseau du mode par défaut chez les rats SHR/NCrl et WKY/NCrl, ainsi que des dysfonctions fronto-striatales associatives spécifiques aux rats SHR/NCrl.Dans la seconde étude, un traitement journalier au MPH, au LDX ou à la GFC a été mis en place chez des rats témoins de l’adolescence à l’âge adulte (mimant un traitement de l’enfance à la fin de l’adolescence chez l’homme). Les effets de ces traitements sur l’activité cérébrale ont été évalués après la première et la dernière injection par imagerie microTEP au 18FDG sur animal éveillé. Nos résultats montrent que chaque médicament a un effet important sur les régions limbiques, et que le LDX présente une action supplémentaire sur des régions associatives et sur les régions du réseau du mode par défaut. A notre connaissance, ce sont les premières données de neuroimagerie en préclinique qui mettent en avant l’implication des régions limbiques liées à la motivation et du réseau du mode par défaut dans la physiopathologie du TDAH. Nos résultats renforcent l’hypothèse selon laquelle les médicaments du TDAH agiraient sur les troubles primaires du TDAH et non en compensant un déficit d’attention par une augmentation de la motivation. Ces résultats suggèrent aussi que (i) la GFC est un non psychostimulant qui présente deseffets similaires au médicament de référence le MPH, et que (ii) le LDX montre un profil d’action intéressant car touchant à la fois les régions limbiques, associatives et le réseau du mode par défaut que nous trouvons toutes perturbées chez les rats SHR/NCrl. / Attention Deficit Hyperactivity Disorders (ADHD) is a neurodevelopment disorder affecting childs and adults presenting attention deficits, hyperactivity and impulsivity. Despite numerous neuroimaging studies on ADHD patients, the specific dysfunctions underlying the symptoms of ADHD remain unknown. To date, ADHD patients can be treated using psychostimulant drugs such as methylphenidate (MPH) and other promising compounds are currently in development (dymesilate-lisdexamfétamine (LDX) and guanfacine (GFC), that are psychostimulant and non psychostimulant medications, respectively). Even if the molecular targets of these medications are well defined, how these compounds will impact the brain activity to reverse ADHD symptoms is less known. The objectives of this work were to study (i) the pathophysiology of ADHD and (i) the effects of an acute or repeated administration of MPH, LDX or GFC using animal models and microPET imaging with 2-deoxy-2-(18F)fluoro-d-glucose (18FDG). First, we used an animal model of ADHD, namely the SHR/NCrl and WKY/NCrl rats that both exhibit attention deficits, with impulsivity-hyperactivity only displayed by SHR/NCrl rats. MicroPET imaging using 18FDG on awake rats was performed to obtain brain metabolic profiles of these animals. Our hypothesis was that SHR/NCrl and WKY/NCrl would shared brain dysfunctions in several regions of interest involved in the attention deficits, while SHR/NCrl rats would also displayed specific abnormalities related to hyperactivity-impulsivity. Our results confirmed these hypothesis as both SHR/NCrl and WKY/NCrl showed metabolic alterations in fronto-striatal limbic regions and in areas of the default mode network. In addition, SHR/NCrl specifically exhibited functional modifications in fronto-striatal associative areas.Second, daily injections with MPH, LDX or GFC were performed on control rats from adolescence to adulthood (corresponding to a treatment from childhood to the end of adolescence in humans). The effects of such treatments were evaluated after the first and the last injections on freely moving rats using microPET imaging with 18FDG. Our results showed that each medication affects the activity of limbic brain regions. In addition, LDX has an interesting profile showing effects also on associative fronto-striatal areas and on thedefault mode network. To our knowledge, these are the first preclinical neuroimaging results highlighting the crucial role of limbic brain regions related to motivation and the default mode network in the pathophysiology of attention deficits in ADHD. These data also reinforce the hypothesis that ADHD medications act on the brain areas primarily involved in the pathophysiology of ADHD. Interestingly, we showed that GFC and MPH shared the same effects on the limbic brain regions suggesting that this non psychostimulant medication is of a great interest for the treatment of ADHD. While MPH and GFC act primarily on limbic circuits, LDX also altered the activity of the default mode network and associative fronto-striatal areas. This support the hypothesis that LDX could be an interesting education for treating ADHD acting on all the systems identified as dysfunctional in the animal models of ADHD.
|
4 |
Effect of knockdown of Giα proteins using antisense oligodeoxynucleotides encapsulated in cationic liposomes on the development of hypertension in spontaneously hypertensive ratsEl-Basyuni, Yousra 11 1900 (has links)
L'hypertension artérielle est l'une des principales causes de morbidité et de mortalité dans le monde. La compréhension des mécanismes qui sont à la base du développement de l'hypertension offrira de nouvelles perspectives pour un meilleur contrôle de l'hypertension. Nous avons précédemment montré que le niveau des protéines Giα-2 et Giα-3 est augmenté chez les rats spontanément hypertendus (SHR) avant l'apparition de l'hypertension. Le traitement avec les inhibiteurs de l’enzyme de conversion de l’Angiotensine (IEC) est associé à une diminution de l’expression des protéines Gi. De plus, l'injection intrapertoneale de la toxine de la coqueluche inactive les deux protéines Giα et empêche le développement de l'hypertension chez les SHR. Cependant, la contribution spécifique des protéines Giα-2 et Giα-3 dans le développement de l'hypertension n'est pas encore connue. Dans la présente étude, l’Anti-sens oligodésoxynucléotide (AS-ODN) de Giα-2 et Giα-3 (1mg/Kg en poids corporel) encapsulé dans des liposomes cationiques PEG / DOTAP/ DOPE ont été administrés par voie intraveineuse aux SHR pré-hypertendus âgé de trois semaines et aux Wistar Kyoto (WKY) rats de même âge. Les contrôles des WKY et SHR non traités ont été injectés avec du PBS stérile, liposomes vides ou oligomères sens. La pression artérielle (PA) a été suivie chaque semaine en utilisant la technique manchon caudal. Les rats ont été sacrifiés à l'âge de six semaines et neuf semaines. Le coeur et l'aorte ont été utilisés pour étudier l'expression des protéines Gi. Le knockdown des protéines Giα-2 par l’injection de Giα-2-AS a empêché le développement de l'hypertension à l'âge de six semaines. Par la suite, la PA a commencé à augmenter rapidement et a atteint le niveau que l'on retrouve dans les groupes témoins à l'âge de neuf semaines. D'autre part, la PA du groupe traité avec le Giα-3-AS a commencé à augmenter à l'âge de quatre semaines. Dans le groupe des SHR-Giα-3-AS, la PA a augmenté à l’âgé de six semaines, mais moins que celle de SHR-CTL. Le coeur et l'aorte obtenues des SHR Giα-2-AS et Giα-3-AS à partir de l’âgé de six semaines ont eu une diminution significative de l’expression des protéines Giα-2 et Giα-3 respectivement. Dans le groupe des WKY Giα-2-AS et Giα-3-AS l'expression des protéines Giα-2 et Giα-3 respectivement a diminué malgré l'absence de changement dans la PA par rapport aux WKY CTL. À l'âge de neuf semaines, les SHR traités avec du Giα-2-AS et Giα-3-AS avaient la même PA et expression des protéines Gi que le SHR CTL. Ces résultats suggèrent que les deux protéines Giα-2 et Giα-3 sont impliqués dans le développement de l'hypertension chez les SHR, mais le knockdown de Giα-2 et pas de Giα-3 a empêché le développement de l'hypertension. / Hypertension is one of the leading causes of morbidity and mortality in the world. Understanding the mechanisms underlying the development of hypertension will provide new insights into better control of hypertension. We have previously shown that the levels of Giα-2 and Giα-3 proteins were augmented in SHR before the onset of hypertension. Antihypertensive (ACE) inhibitor is associated with decreased Gi-proteins. In addition, intrapertoneal injection of pertussis toxin (PTX) inactivated both Giα proteins and prevented the development of hypertension in SHR. However, the specific contribution of Giα-2 and Giα-3 proteins in hypertension development is still not known.
In the present study, Giα-2 and Giα-3 Antisense oligodeoxynuleotide (AS-ODN) (1 mg/Kg body weight) encapsulated in PEG/DOTAP/DOPE cationic liposomes were administrated intravenously to three-week-old pre-hypertensive SHR and their age-matched WKY while control WKY and SHR were injected with sterile PBS, empty liposomes or sense oligomer. Blood pressure (BP) was monitored weekly using tail-cuff technique. The rats were sacrificed at the age of six weeks and nine weeks. Heart and aorta were used to study Gi proteins expression. The knockdown of Giα-2 protein by Giα-2-AS injection prevented the development of hypertension up to the age of six weeks; thereafter the BP began to increase rapidly and reached the same level found in control groups at the age of nine weeks. On the other hand, the BP of the Giα-3-AS treated group began to increase at the age of four weeks. The SHR Giα-3-AS had augmented BP at six weeks but lower than that of SHR-CTL. The heart and aorta obtained from six week-old SHR Giα-2-AS and Giα-3-AS had significant decrease in Giα-2 and Giα-3 proteins expression respectively. WKY Giα-2-AS and Giα-3-AS had decreased in Giα-2 and Giα-3 protein expression respectively despite having no change in BP compared to CTL WKY. At the age of nine weeks, the SHR Giα-2-AS and Giα-3-AS had the same BP and Gi protein expression as the control SHR. These results suggest that both Giα-2 and Giα-3 proteins are implicated in the development of hypertension in SHR but the knockdown of Giα-2 not Giα-3 has prevented the development of hypertension.
|
5 |
Studium beta-adrenergní signalizace v myokardu spontánně hypertenzního potkana transgenního kmene SHR-Tg19 / A study of beta-adrenergic myocardial signaling in spontaneously hypertensive rat of transgenic strain SHR-Tg19Manakov, Dmitry January 2012 (has links)
β-Adrenergic signalization plays an important role in heart, regulating cardiac frequency and contractility. It is also involved in development of hypertension and heart hypertrophy. Spontaneous hypertensive rat strain is a common model for human essential hypertension, although the origin of blood pressure abnormalities in SHR remains unknown. Dysfunction in the regulation of fatty acid translocase Cd36 was suggested as a link to development of hypertension in SHR. Transgenic strain SHR-Tg19 (also known as SHR-Cd36) was obtained, harboring a wild type of FAT/Cd36. This thesis aimed to investigate key elements of β-adrenergic signaling in the heart of SHR-Tg19 compared to their SHR controls. Expression and distribution of β1- and β2-ARs were measured using radioligand binding and Western blot analysis along with expression of selected G proteins and expression and activity of adenylyl cyclase. Our experiments showed that there were no significant changes in the Gsα and Giα subunits expressions, along with the amount of β1-AR in both left and right ventricles, according to the Western immunoblotting, but radioligand binding showed an increase in the quantity of β-ARs, particularly β2 subtype. Alongside, an increased expression of β2- ARs was observed in the right ventricle. Different...
|
6 |
Characterisation of Grape and Grape pomace Polyphenolics : their Absorption and Metabolism and Potential Effects on Hypertension in a SHR Rat Model / Caractérisation d’Antioxydants Phénoliques de Raisins et de Marcs : leur Absorption, Métabolisme et Effets Potentiels sur l’Hypertension dans un Modèle de Rats SHR (Spontanément Hypertendus)Ky, Isabelle 13 December 2013 (has links)
Cette étude examine les effets bénéfiques des marcs de raisins obtenus après vinification de différents cépages caractéristiques de la Vallée du Rhône, de leurs compositions phénoliques à leurs effets in vivo. Les raisins et leurs marcs respectifs des cépages Grenache (provenant de deux endroits différents [GRE1] et [GRE2]), Syrah (provenant de deux endroits différents [SYR1] et [SYR2]), Carignan (CAR), Mourvèdre (MOU), Counoise (COU) et Alicante (ALI) ont été étudiés. La comparaison des extraits de raisins et de leurs marcs respectifs montre que les marcs représentent une source importante d’antioxydants phénoliques malgré le processus de vinification. Les pépins et pellicules de marcs renferment des quantités appréciables de flavan-3-ols et anthocyanes. La distribution qualitative et quantitative des polyphenols dans les marcs de raisin présentent des différences significatives au travers des variétés et millésimes allant de 15% à 70% de polyphénols extraits. Les pépins de Grenache (GRE1), Syrah (SYR1) et les pellicules de Syrah (SYR1), Carignan et Alicante sont les fractions les plus intéressantes dues a la présence d’importantes quantités de flavan-3-ols (monomères, dimères et trimère) jusqu’à 8.7 mg/g MS et d’anthocyanes (glycosylées, acétylées et coumaroylées jusqu’à 17.40 mg/g MS, 1.57 mg/g MS et 2.38 mg/g MS respectivement). L’analyse des extraits aqueux (EAQ) et hydro-alcoolique 70% (EA70) indique que les pépins de Carignan et Syrah (SYR1) et les pellicules de Carignan et d’Alicante contiennent les plus fort taux en composés phénoliques et activités antioxydantes. L’efficacité in vivo sur l’hypertension de certains extraits a été évaluée utilisant un modèle de rat SHR. Les résultats des expériences in vivo démontrent que certains extraits administrés seuls ou en association avec le vérapamil possèdent un effet anti-hypertenseur. Cette capacité a été mise en évidence une fois que les extraits de pépins de marcs de GRE1 (EA70) et SYR1 (EA70) et de pellicules de marcs d’ALI (EA70) ont été administrés seuls ou lorsque les extraits de pépins de marcs GRE1 (EA70) et SYR1 (EAQ) et les pellicules de marcs d’ALI (EA70) et SYR2 (EAQ) ont été administrés en association avec le vérapamil. Cette étude met en évidence la biodisponibilité des extraits de pépins et de pellicules de marcs des rats SHR incluant à la fois le métabolisme de phase II et de la microflore intestinale. Les extraits de marcs administrés seuls et en association au vérapamil sont absorbés en tant que métabolites de phase II dérivant du métabolisme des monomères de flavan-3-ols. La détection de métabolites microbiens dérivés de flavan-3-ols, d’hydroxyphényl-γ-valérolactones sous leurs formes glucuronidés et sulfatés confirme l'absorption des métabolites dérivés des flavan-3-ols monomères et polymères et des conjugaisons supplémentaires dans le foie. De nombreux métabolites issus de la dégradation microbienne des hydroxyvalerolactones ont également été détectés. L’excrétion urinaire de ces métabolites représente une plus grande proportion de polyphénols ingérés comparé à ceux issus de métabolisme de phase II des monomères de flavan-3-ols, indiquant un rôle important des bactéries intestinales dans le métabolisme des molécules hautement polymérisées. Ces métabolites peuvent avoir exercé leurs effets biologiques lors de leur passage dans la circulation sanguine. Cette étude constitue une première étape de valorisation de marcs de raisins après vinification, en tant qu’activateur de vérapamil, un médicament couramment utilisé contre l’hypertension. Des quantités suffisantes de composés phénoliques subsistent dans les marcs, en particulier en terme de flavan-3-ols et d’anthocyanes, pour exercer des effets antihypertenseurs. En effet, selon le type et la composition des extraits, il est possible de moduler les effets antihypertenseurs en amplifiant ou en diminuant l’absorption des polyphénols et/ou du vérapamil. / This study investigated the beneficial potential effects of grape pomaces obtained after winemaking of different Mediterranean grape varieties from crude materials to their in vivo effectiveness. Grapes and their respective grape pomaces from six different V. vinifera L. cultivar were studied namely Grenache (from two different locations [GRE1 and GRE2]), Syrah (from two different locations [SYR1 and SYR2]), Carignan (CAR), Mourvèdre (MOU), Counoise (COU) and Alicante (ALI) grape varieties from the Rhône Valley. The comparison of several wine industry by-products with their respective grapes provided evidence that pomace remaining at the end of the winemaking process can be very rich sources of antioxidants. The quantitative and qualitative distribution of polyphenols by HPLC-PDA-Fluo-MS in grape pomaces showed significant differences through varieties and vintages varying from 15% to 70% of polyphenols extracted. Seeds from Grenache (GRE1), Syrah (SYR1) and skins from Syrah (SYR1), Carignan and Alicante were of particular interest because of their higher polyphenol contents in terms of flavan-3-ols (monomers, dimers and trimers) up to 8.7 mg/g DW and anthocyanins (glycosides, acetylated and coumaroylated derivatives up to 17.40, 1.57 and 2.38 mg/g DW, respectively). The investigation of aqueous and hydro-alcoholic 70% extracts of seeds from Carignan and Syrah (SYR1) and skins from Carignan and Alicante was carried out as they contained high levels of total phenols and antioxidant activity. Several extracts, were tested in order to evaluate their in vivo biological effects on hypertension using a spontaneously hypertensive rat (SHR) model. A series of different grape pomace extracts were tested in association with verapamil. All in vivo experiments demonstrated that some grape pomace extracts administrated with or without co-ingestion with verapamil possessed an anti-hypertensive activity. This was evident with GRE1 (EA70) seed pomace extract, SYR1 (EA70) seed pomace extract, ALI (EA70) skin pomace extract administrated alone and with GRE1 (EA70) seed pomace extract, SYR1 (EAQ) seed pomace extract, ALI (EA70) skin pomace extract and SYR2 (EAQ) skin pomace extract administrated in association with verapamil. Grape pomace extracts with or without co-ingestion with verapamil were absorb as phase II metabolites mainly including glucuronide, O-methyl glucuronide, sulfate, and O-methyl sulfate derivatives of (epi)catechin which arise from the metabolism of monomeric flavan-3-ols. The detection by HPLC-PDA-Fluo-MSn and GC-MS of microbial-derived metabolites of flavan-3-ols, hydroxyphenyl-γ-valerolactones in their glucuronide and sulfate forms confirmed the absorption of metabolites derived from both monomeric and polymeric flavan-3-ols from grape pomace extracts and subsequent post-absorption conjugation. Numerous metabolites derived from further microbial degradation of hydroxyvalerolactones were also detected. The urinary excretion of these metabolites accounted for a larger proportion of the total polyphenol ingested than phase II metabolites of monomeric flavan-3-ols, indicating the important role of intestinal bacteria in the metabolism of polymerized procyanidins. All these metabolites may have exerted biological effects during the period in which they circulated in the bloodstream. This study constitutes the first step of assessing grape pomace as an enhancer of the verapamil, an anti-hypertensive drug. Substantial levels of polyphenols, especially flavan-3-ols, procyanidins and anthocyanins, remain in pomace after the winemaking process in quantities sufficient to exert anti-hypertensive effects. In addition, according to the extract used and its composition, it is feasible to modulate anti-hypertensive effects by amplifying or decreasing polyphenols and/or verapamil absorption.
|
7 |
The Cardiovascular Effects of alpha-Melanocyte-Stimulating Hormone in the Nucleus Tractus Solitarii of Spontaneously Hypertensive RatsWeng, Wen-Tsan 09 August 2004 (has links)
alpha-melanocyte stimulating hormone (alpha-MSH) is an important regulator of food intake, metabolic rate, and inflammation. Recently, alpha-MSH was shown to influence sympathetic activity and blood pressure regulation. In the present study, we investigated the cardiovascular effects of alpha-MSH in the nucleus tractus solitarii (NTS) of spontaneously hypertensive rats (SHR). Because nitric oxide (NO) is well-known to involve in central cardiovascular regulation, we elucidated the role of NO in the cardiovascular responses induced by alpha-MSH. In urethane-anesthetized SHR, unilateral microinjection of alpha-MSH (0.3-300 pmol) into the NTS produced dose-responsive depressor and bradycardic effects. The cardiovascular effects of alpha-MSH were abrogated by the antagonist of melanocortin receptor (MC3/4-R), SHU9119. Pretreatment with precursor of nitric oxide, L-arginine, enhanced the duration of alpha-MSH-mediated hypotensive effects, whereas prior application of L-NAME, a universal inhibitor of nitric oxide synthase (NOS), significantly attenuated the effects of alpha-MSH. Prior injection with inhibitor of inducible NOS, aminoguanidine, but not inhibitor of neuronal NOS, 7-nitroindazole, attenuated the hypotensive effect of alpha-MSH. In summary, these results indicated alpha-MSH induced depressor and bradycardic effects in the NTS of SHR. Besides, the hypotensive mechanism of alpha-MSH was mediated via MC4-R and involved with iNOS activation in the NTS of SHR.
|
8 |
Le niveau réduit d’AMPc dans la surexpression des protéines G(alpha)i et la prolifération accrue des cellules du muscle lisse vasculaire des rats spontanément hypertendusGusan, Svetlana 04 1900 (has links)
Nous avons précédemment montré que les cellules musculaires lisses vasculaires(CMLV)
des rats spontanément hypertendus (SHR) présentent une expression augmentée des protéines G inhibitrices (Gi) et une prolifération cellulaire accrue par rapport aux CMLV des rats Wystar-Kyoto (WKY). Le niveau d'AMPc s’est également avéré plus faible dans les CMLV de SHR. La présente étude a donc été entreprise afin d'examiner la contribution de la diminution du niveau intracellulaire d'AMPc à l’augmentation de l'expression des protéines Gi et à la prolifération accrue des CMLV de SHR et de continuer à explorer les mécanismes moléculaires sous-jacents responsables de cette réponse. Les CMLV de SHR ont montré par rapport aux CMLV des WKY une expression accrue de Giα-2 et Giα-3 qui a été diminué d'une manière dépendante de concentration par le dbcAMP, un analogue d'AMPc perméable à la membrane cellulaire. En outre, les fonctions augmentées des protéines Gi comme démontrées par l'amplification de l’inhibition de l'adénylate cyclase par les hormones inhibitrices et l'activité forskoline (FSK)-stimulée de l’adénylate cyclase par une faible concentration de GTPγS dans les CMLV de SHR ont également été restaurées aux niveaux de WKY par le dbcAMP. La prolifération accrue des CMLV de SHR a également été atténuée par le dbcAMP et la forskoline, un activateur de l'adénylate
cyclase. De plus, dbcAMP a restauré la production augmentée d'anion superoxyde (O2-), l'activité de la NAD(P)H oxydase et l’expression accrue des protéines Nox 4 et p47phox observée dans les CMLV de SHR jusqu’au niveau contrôle. Par ailleurs, la phosphorylation accrue des PDGF-R, EGF-R, c-Src et ERK1/2 énoncée par les CMLV de SHR a également été diminuée par le dbcAMP d'une manière dépendante de concentration. Ces résultats suggèrent que le niveau réduit d'AMPc intracellulaire montré par les CMLV de SHR contribue à l'expression accrue des protéines Gi et à l’hyperprolifération cellulaire à travers l’augmentation du stress oxydatif, la transactivation des EGF-R, PDGF-R et la voie de signalisation des MAP kinases. / We have previously shown that vascular smooth muscle cells (VSMC) from spontaneously
hypertensive rats (SHR) exhibit enhanced expression of inhibitory G proteins (Gi) and
enhanced cell proliferation as compared to VSMC from Wystar-Kyoto rats (WKY). The levels of cAMP were shown to be decreased in VSMC from SHR. The present study was therefore undertaken to examine the contribution of the decreased intracellular level of cAMP in the enhanced expression of Gi proteins and increased proliferation of VSMC from SHR and to further explore the underlying molecular mechanisms responsible for this response. VSMC from SHR showed an enhanced expression of Giα-2 and Giα-3 as compared to VSMC from WKY which was decreased in a dose-dependent manner by dbcAMP, a cell-permeable cAMP analog. In addition, the enhanced functions of Gi proteins as demonstrated by enhanced inhibition of adenylyl cyclase by inhibitory
hormones and forskolin (FSK)-stimulated adenylyl cyclase activity by low concentration of GTPγS in VSMC from SHR were also restored to the WKY levels by dbcAMP. The enhanced proliferation of VSMC exhibited by SHR was also attenuated by dbcAMP and
forskolin, an activator of adenylyl cyclase. In addition, dbcAMP also restored the increased production of superoxide anion (O2-), NAD(P)H oxidase activity and enhanced expression of Nox 4 and p47phox proteins observed in VSMC from SHR to control levels. Furthermore, the increased phosphorylation of PDGF-R, EGF-R, c-Src and ERK1/2 exhibited by VSMC from SHR were also decreased by dbcAMP in a dose-dependent manner. These results
suggest that decreased levels of intracellular cAMP exhibited by VSMC from SHR
contributes to the enhanced expression of Gi proteins and hyperproliferation through increasing oxidative stress and transactivation of EGF-R, PDGF-R and MAP kinase signaling pathway.
|
9 |
Le niveau réduit d’AMPc dans la surexpression des protéines G(alpha)i et la prolifération accrue des cellules du muscle lisse vasculaire des rats spontanément hypertendusGusan, Svetlana 04 1900 (has links)
Nous avons précédemment montré que les cellules musculaires lisses vasculaires(CMLV)
des rats spontanément hypertendus (SHR) présentent une expression augmentée des protéines G inhibitrices (Gi) et une prolifération cellulaire accrue par rapport aux CMLV des rats Wystar-Kyoto (WKY). Le niveau d'AMPc s’est également avéré plus faible dans les CMLV de SHR. La présente étude a donc été entreprise afin d'examiner la contribution de la diminution du niveau intracellulaire d'AMPc à l’augmentation de l'expression des protéines Gi et à la prolifération accrue des CMLV de SHR et de continuer à explorer les mécanismes moléculaires sous-jacents responsables de cette réponse. Les CMLV de SHR ont montré par rapport aux CMLV des WKY une expression accrue de Giα-2 et Giα-3 qui a été diminué d'une manière dépendante de concentration par le dbcAMP, un analogue d'AMPc perméable à la membrane cellulaire. En outre, les fonctions augmentées des protéines Gi comme démontrées par l'amplification de l’inhibition de l'adénylate cyclase par les hormones inhibitrices et l'activité forskoline (FSK)-stimulée de l’adénylate cyclase par une faible concentration de GTPγS dans les CMLV de SHR ont également été restaurées aux niveaux de WKY par le dbcAMP. La prolifération accrue des CMLV de SHR a également été atténuée par le dbcAMP et la forskoline, un activateur de l'adénylate
cyclase. De plus, dbcAMP a restauré la production augmentée d'anion superoxyde (O2-), l'activité de la NAD(P)H oxydase et l’expression accrue des protéines Nox 4 et p47phox observée dans les CMLV de SHR jusqu’au niveau contrôle. Par ailleurs, la phosphorylation accrue des PDGF-R, EGF-R, c-Src et ERK1/2 énoncée par les CMLV de SHR a également été diminuée par le dbcAMP d'une manière dépendante de concentration. Ces résultats suggèrent que le niveau réduit d'AMPc intracellulaire montré par les CMLV de SHR contribue à l'expression accrue des protéines Gi et à l’hyperprolifération cellulaire à travers l’augmentation du stress oxydatif, la transactivation des EGF-R, PDGF-R et la voie de signalisation des MAP kinases. / We have previously shown that vascular smooth muscle cells (VSMC) from spontaneously
hypertensive rats (SHR) exhibit enhanced expression of inhibitory G proteins (Gi) and
enhanced cell proliferation as compared to VSMC from Wystar-Kyoto rats (WKY). The levels of cAMP were shown to be decreased in VSMC from SHR. The present study was therefore undertaken to examine the contribution of the decreased intracellular level of cAMP in the enhanced expression of Gi proteins and increased proliferation of VSMC from SHR and to further explore the underlying molecular mechanisms responsible for this response. VSMC from SHR showed an enhanced expression of Giα-2 and Giα-3 as compared to VSMC from WKY which was decreased in a dose-dependent manner by dbcAMP, a cell-permeable cAMP analog. In addition, the enhanced functions of Gi proteins as demonstrated by enhanced inhibition of adenylyl cyclase by inhibitory
hormones and forskolin (FSK)-stimulated adenylyl cyclase activity by low concentration of GTPγS in VSMC from SHR were also restored to the WKY levels by dbcAMP. The enhanced proliferation of VSMC exhibited by SHR was also attenuated by dbcAMP and
forskolin, an activator of adenylyl cyclase. In addition, dbcAMP also restored the increased production of superoxide anion (O2-), NAD(P)H oxidase activity and enhanced expression of Nox 4 and p47phox proteins observed in VSMC from SHR to control levels. Furthermore, the increased phosphorylation of PDGF-R, EGF-R, c-Src and ERK1/2 exhibited by VSMC from SHR were also decreased by dbcAMP in a dose-dependent manner. These results
suggest that decreased levels of intracellular cAMP exhibited by VSMC from SHR
contributes to the enhanced expression of Gi proteins and hyperproliferation through increasing oxidative stress and transactivation of EGF-R, PDGF-R and MAP kinase signaling pathway.
|
10 |
Avaliação do estresse oxidativo e modulação autonômica cardiovascular pós-irradiação de laser de baixa intensidade em ratos espontaneamente hipertensos: estudo experimentalTomimura, Suely 17 December 2013 (has links)
Submitted by Nadir Basilio (nadirsb@uninove.br) on 2015-07-20T18:01:54Z
No. of bitstreams: 1
Suely Tomimura.pdf: 1781054 bytes, checksum: acaac7dbd088721fbe65530e5cd96c5f (MD5) / Made available in DSpace on 2015-07-20T18:01:54Z (GMT). No. of bitstreams: 1
Suely Tomimura.pdf: 1781054 bytes, checksum: acaac7dbd088721fbe65530e5cd96c5f (MD5)
Previous issue date: 2013-12-17 / Due to the increasing numbers of Systemic Arterial Hypertension (HBP) patients in population and its senescence, steadily increased from 600 million in 1980 to 1.2 billion in 2008. The World Health Organization (WHO) in 2009 attributed to high blood pressure (BP) was the death cause for 9.5 million people worldwide. Currently, the hypertension has become a serious public health problem. This entity is an important risk factor for congestive heart failure, cerebrovascular disease, acute myocardial infarction, nephropathy, retinopathy and peripheral vascular insufficiency. Studies have suggested that laser photobiomulation, employing a low power, acts into the inflammatory and proliferative phases of tissue repair, by modulating the inflammatory mediators synthesis as same as the Reactive Oxygen Species (ROS). According scientific publications indicate that the inflammation component is closely related to systemic arterial hypertension as well as possibly to the oxidative stress, both participates in the Hypertension genesis. The aim of this study was to verify the long-term effects of Low Level Laser Therapy (LLLT) application in Spontaneously Hypertensive Rats-SHR (Spontaneously Hypertensive Rats) through on cardiovascular autonomic modulation and oxidative stress in the blood. The experiment consisted in 3 phases: Phase I – LLLT irradiation on SHR: The experiment's phase I consisted of animal’s irradiation, when the laser group received three times LLLT applications weekly for a 7 weeks total; the sham group received three times per week of LLLT simulation for 7 weeks and a total of 21 applications. Prospective, randomized, controlled study, with 16 SHR approximately 2 months age, randomly divided into 2 groups : Sham (n = 8) and Laser (n = 8). The animals were irradiated in a prompt, onto the tail’s dorsal area, using a Diode Laser (MMOptics, São Carlos, SP, Brazil) with a wavelength (λ) of 780 ± 2 (nm), output power at 40 mW, with a 0.04 cm2 beam area, dose of 30 J/cm2 power density of 1W/cm2 and irradiation time of 90 s. In Phase II - Hemodynamic and autonomic cardiovascular evaluation: for a period of 7 weeks, consisted in the cannulation procedure, collecting and analysis. The animals were cannulated, evaluated hemodynamically and analyzed the cardiovascular autonomic modulation. Phase III - Oxidative stress analysis, were analyzed: a) protein damage; b) cell membrane damage; c) antioxidant enzyme activity; d) nitrite concentrations. Data from phase II and III were collected and statistically analyzed applying One Way ANOVA test, followed by post hoc Student - Newman Keulls and considering the significance level of p < 0.05, equivalent to an error α 0.05. The results demonstraded hemodynamic parameters of group LLLT treated showed a BP reduction, when compared with the Sham group. In laser group the diastolic arterial pressure (DAP) showed a reduction of -14 mmHg (± 143 * 4 x 157 ± 3 mmHg Sham) and mean arterial pressure (MAP) - 13mmHg (169 ± 4 * x 182 ± 4 mmHg Sham) there were statistically significant difference. Although the value of systolic arterial pressure (SAP) (196 ± 5 x 207 ± 4 mmHg) showed no differences. There was a decreased in resting HR with a statistically significant difference in the laser group compared to Sham (312 ± 14 vs. 361 ± 13 bpm sham). The spectral reviews in the field of time and frequency showed that the Laser group decreased sympathetic activity on the heart and blood vessels while compared to the Sham group. The heart rate variation was analyzed using the DP-PI ( standard deviation of the pulse interval) VAR-PI components (pulse interval variability) and it demonstrated that LLLT was effective in diminishing variation in heart rate (HR) and sympathetic activity in heart, inducing a substantial fall in blood pressure. Lasertherapy presented a rise in spectral low-frequency component in the pulse interval (LF - IP action of the sympathetic at heart), though the sham group showed up exaggeratedly decreasing (6.77 ± 4:35 and 2:31 ± 0:16 ms ² Sham) as a function of saturation variation. Thus, there was a significant reduction in sympathetic activity after LLLT using. A high-frequency band on interval pulse HF-IP (parasympathetic activity) showed no statistically significant differences between the groups and Laser Sham group. The baroreceptor sensitivity, assessed by the alpha index, signalized a significant increase in the Laser (1:07 ± 0:23 vs. 0:45 ± 0:20 ms / mmHg Sham) group, presenting an improvement in the receptors sensitivity. The baroreflex results were associated with other relevant data, the VAR - SAP (49.55 ± 15.94 * vs 70.51 ± 13:55 mmHg² Sham) and SD -SAP (6.94 ± 1.21 * vs 8.68 ± 1.11 mmHg Sham) that proved to be diminished in the laser group, indicating baroreflex improvement sensitivity concomitantly to the positive SAP variation reduction of. There were no significant differences in baseline SAP (196 ± 5 vs. 207 ± 4 mmHg Sham) between the two groups. The results in the oxidative stress and autonomic analysis demonstrated an association between increased NO production (nitrite 0:36 ± 0:03 vs 0:26 ± 0:03 nm / mg Sham) and decreased in the vascular sympathetic (LF - SAP 7.28 ± 1.63 * vs 9.86 ± 0.47 Sham), both leading to a profound vasodilatation then a significant fall in of blood pressure. Lasertherapy shown to alter the plasma parameters such as oxidative nitrite, revealing an NO increased metabolism, as described above and, moreover, accounted for a significant reduction in carbonyl plasma concentration (vs 3.93 ± 0.24, 4.75 ± 0:26 * nm / mg Sham). Our experimental study indicate that LLLT was able to reduce the oxidative stress parameters through diminishing the damage to the proteins. The enzymatic defense was analyzed by the enzyme SOD concentration in blood plasma, denoted that no significant differences (4:42 ± 0:10 4:25 ± 0:06 vs usod / mg) between groups. Thus, low level laser therapy has shown to improve cardiovascular autonomic activity as well as oxidative parameters which resulted in steadily staggeringly reduce the blood pressure of hypertensive animals. / Em razão do aumento populacional e a senescência, o número de indivíduos com Hipertensão Arterial Sistêmica (HAS) cresceu de 600 milhões em 1980 para 1,2 bilhões (OMS 2011). Lim (2012) atribuiu que a pressão arterial (PA) elevada fosse a causa mortis de 9,5 milhões de indivíduos ao redor do mundo. Atualmente, a HAS tornou-se um grave problema de saúde pública. A hipertensão é um importante fator de risco para insuficiência cardíaca congestiva, doenças cerebrovasculares, infarto agudo do miocárdio, nefropatia, insuficiência vascular periférica e retinopatia hipertensiva. Considerando publicações científicas que demonstram que o componente da inflamação e do estresse oxidativo estão intimamente relacionados à gênese da hipertensão arterial sistêmica (HAS), e que o laser com potência baixa tem efeito positivo no estresse oxidativo e apresenta ação antiinflamatória eficaz, desta forma buscamos estudar a resposta da Laserterapia na HAS. Inúmeros estudos vêm sugerindo, ao longo de décadas, que a fotobiomulação pelo laser empregado uma potência baixa, atua durante as fases inflamatórias e proliferativas da reparação tissular, modulando síntese de mediadores inflamatórios e espécies reativas de oxigênio (ROS). O objetivo deste estudo foi analisar os efeitos da aplicação do laser de baixa intensidade em ratos espontaneamente hipertensos SHR (Spontaneously Hypertensive Rats) em longo prazo na modulação autonômica cardiovascular e no estresse oxidativo sangúineo. Estudo prospectivo, randomizado e controlado com 16 ratos SHR, divididos aleatoriamente em 2 grupos: Sham (n=8) e Laser (n=8).O experimento foi dividido em três fases: Fase I – Irradiação dos animais: constituiu-se na irradiação com laser nos animais SHR, onde o grupo Laser recebeu três aplicações semanais de LBI durante sete semanas; já no grupo Sham foram realizados três simulações de aplicação semanais de Laser de Baixa Intensidade (LBI) durante 7 semanas, totalizando 21 aplicações de LBI. Os animais foram irradiados pontualmente, na região dorsal da cauda, utilizando um Laser Diodo (MMOptics, São Carlos, SP, Brasil) com comprimento de onda de λ = 780 ± 2 (nm); potência de 40 mW, área do feixe de 0,04 cm2, densidade de energia de 30 J/cm2, densidade de potência de 1W/cm2, tempo total de irradiação de 90 s de exposição. Fase II – Avaliação hemodinâmica e autonômica cardiovascular: constituiu-se nos procedimento de canulação, registro de dados e coleta de material, teve inicio após sete semanas de irradiação. Os animais canulados foram avalidados de forma hemodinâmica, bem como analisada a modulação autonômica cardiovascular. Fase III – Análises do estresse oxidativo, foram analisadas: a) danos à proteína; b) danos à membrana celular; c) atividade enzimática; d) concentração de nitrito. Os dados da fase II e III foram coletados e analisados estatisticamente através dos testes Anova One Way, seguido de Post Hoc de Student Newman-Keulls, considerando-se o nível de significância p < 0,05, equivalendo a um erro α de 0.05. Os resultados hemodinâmicos do grupo tratado com LLLT denotaram um decréscimo significativo da PA quando comparado com o grupo Sham. A pressão arterial diastólica (PAD) do grupo Laser revelou uma redução de -14 mmHg (143± 4*vs157±3 mmHg Sham) e a pressão arterial média (PAM) -13mmHg (169±4*vs182±4 mmHg Sham), a frequência cardíaca (FC) em repouso (312±14*vs361±13 bpm Sham) revelando uma diferença estatisticamente significante, porém o valor da pressão arterial sistólica(PAS) não mostrou (196±5 x 207±4 mmHg) alterações entre os grupos. As avaliações espectrais no domínio do tempo e da frequencia demostraram que o grupo Laser reduziu a atividade simpática sobre o coração e vasos sanguíneos quando comparados ao grupo Sham. A variação frequência cardíaca foi analisada através dos componentes VAR-IP (variabilidade do intervalo de pulso) e o DP-IP (desvio do intervalo de pulso) que evidenciaram que o LBI foi eficaz no decréscimo variação da FC e da atividade simpática no coração, induzindo assim a queda das pressões arteriais. A laserterapia mostrou um incremento no componente espectral baixa frequência no intervalo de pulso (BF-IP ação do simpático no coração), porém o grupo Sham apresentou-se exacerbadamente diminuído (6.77 ± 4.35 e 2.31±0.16 ms² Sham) em função da saturação da variação desse componente que foi reduzido. Desta forma, houve um importante decréscimo da atividade simpática com o uso do LBI, significando uma importante diminuição dos níveis pressóricos. A banda de alta frequência (AF-IP atividade parassimpática cardíaca) não mostrou diferenças estatísticas significantes entre os grupos Laser e grupo Sham. A sensibilidade dos barorreceptores, avaliada pelo índice alfa, demonstrou um significativo incremento da resposta no grupo Laser (1.07 ± 0.23 vs 0.45 ± 0.20 ms/mmHg Sham), revelando uma melhora na sensibilidade destes receptores. Os resultados dos barorreflexos encontravam-se associados a outro dado relevante, o componente VAR-PAS (49.55 ± 15.94* vs 70.51 ± 13.55 mmHg² Sham) e DP-PAS (6.94 ± 1.21* vs 8.68 ± 1.11 mmHg Sham) que mostrou-se diminuído no grupo Laser, indicando que a melhora da sensibilidade barorreflexa ocorreu, concomitantemente, à redução positiva da variação da PAS. Não houve diferenças estatísticas significantes na PAS basal (196±5 vs 207 ± 4 mmHg Sham) entre os dois grupos. Já os resultados encontrados na análise do estresse oxidativo e autonômica demonstraram uma associação entre o incremento da produção do óxido nitrico (NO) (nitrito 0.36 ± 0.03 vs 0.26 ± 0.03 nm/mg Sham) e redução do simpático vascular (BF-PAS 7.28 ± 1.63* vs 9.86 ± 0.47 Sham), ambos levando a uma vasodilatação com consequente queda dos níveis pressóricos arteriais. A laserterapia mostrou alterar parâmetros oxidativos como as espécies reativas de nitrogênio (RNS reactive nitrogen species), o nitrito plasmático, revelando um aumento do metabolismo do NO, como já descrito anteriormente e denotou uma diminuição significativa da concentração de carbonilas plasmáticas (3.93 ± 0.24 * vs 4.75 ± 0.26 nm/mg Sham). A defesa enzimática foi analisada através da concentração da enzima SOD no plasma sanguíneo, que não apontou diferenças significativas (4.42 ± 0.10 vs 4.25 ± 0.06 usod/mg) entre os grupos. Evidenciamos que o LBI foi capaz de reduzir este parâmetro oxidativo, reduzindo os danos às proteínas decorrente do estresse. Desta forma, concluímos que a laserterapia demonstrou resposta positiva ao melhorar a atividade autonômica cardiovascular e parâmetros oxidativos que resultaram na redução dos níveis pressóricos dos animais hipertensos.
|
Page generated in 0.0492 seconds